Novartis Investigative Site

Gloucester GL1 3NN

0 studies enrolling now · 1 studies all time

What they study most

Philadelphia Chromosome-Positive Chronic Myeloid Leukemia

Studies at this site

• A Study to Investigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP) — Running, not enrolling